MCL coexpression mm9:150

Phase1 CAGE Peaks

	Short description
Mm9::chr10:14265002..14265011,-	p10@Gpr126
Mm9::chr10:14265012..14265031,-	p8@Gpr126
Mm9::chr10:79240006..79240025,+	p1@Fstl3
Mm9::chr11:118289807..118289823,+	p6@C1qtnf1
Mm9::chr11:55223709..55223714,-	p@chr11:55223709..55223714 -
Mm9::chr11:78738676..78738699,+	p@chr11:78738676..78738699 +
Mm9::chr11:96829969..96829987,-	p2@Sp2
Mm9::chr12:72990438..72990453,+	p8@Daam1
Mm9::chr12:82891876..82891885,-	p@chr12:82891876..82891885 -
Mm9::chr12:82891888..82891927,-	p@chr12:82891888..82891927 -
Mm9::chr12:84866993..84867019,+	p2@Dcaf4
Mm9::chr13:13274979..13274984,+	p1@Prl2c5
Mm9::chr13:15899074..15899076,+	p1@uc007pnt.1
Mm9::chr13:27288509..27288515,+	p1@Prl3c1
Mm9::chr13:27808598..27808610,-	p1@Prl7d1
Mm9::chr13:27941208..27941211,+	p1@Prl2c1
Mm9::chr13:33119277..33119288,+	p2@Serpinb9b
Mm9::chr13:33119371..33119382,+	p3@Serpinb9b
Mm9::chr13:33251606..33251624,-	p1@Serpinb9c
Mm9::chr13:33576653..33576656,+	p1@Serpinb9g
Mm9::chr13:49394018..49394026,-	p8@Fgd3
Mm9::chr14:55273056..55273059,-	p@chr14:55273056..55273059 -
Mm9::chr14:70723551..70723560,-	p5@Slc39a14
Mm9::chr14:8827051..8827068,-	p4@Dnase1l3
Mm9::chr14:8827077..8827098,-	p5@Dnase1l3
Mm9::chr15:25065377..25065406,-	p@chr15:25065377..25065406 -
Mm9::chr15:78324802..78324811,-	p@chr15:78324802..78324811 -
Mm9::chr17:43526528..43526543,+	p3@Gpr116
Mm9::chr18:61265215..61265233,+	p2@Csf1r
Mm9::chr18:61265294..61265308,+	p5@Csf1r
Mm9::chr18:61265316..61265321,+	p7@Csf1r
Mm9::chr1:168931588..168931602,+	p3@Fam78b
Mm9::chr2:173946349..173946361,+	p@chr2:173946349..173946361 +
Mm9::chr4:150294263..150294306,+	p2@Tnfrsf9
Mm9::chr4:43740117..43740134,+	p4@Hrct1
Mm9::chr4:98365792..98365802,-	p@chr4:98365792..98365802 -
Mm9::chr5:115211954..115211984,-	p@chr5:115211954..115211984 -
Mm9::chr5:122656801..122656838,+	p6@Hvcn1
Mm9::chr5:125523164..125523188,-	p8@Ncor2
Mm9::chr5:125523411..125523420,-	p24@Ncor2
Mm9::chr5:135041416..135041431,-	p@chr5:135041416..135041431 -
Mm9::chr5:138086923..138086948,-	p1@Irs3
Mm9::chr5:138086952..138086965,-	p2@Irs3
Mm9::chr5:75551972..75551981,+	p7@Pdgfra
Mm9::chr6:115311308..115311317,+	p10@Pparg
Mm9::chr6:121293070..121293091,+	p5@Slc6a12
Mm9::chr6:137731436..137731455,+	p@chr6:137731436..137731455 +
Mm9::chr7:114835354..114835373,+	p4@Ppfibp2
Mm9::chr7:118226122..118226145,-	p13@Eif4g2
Mm9::chr7:149720488..149720503,+	p5@Mrpl23
Mm9::chr7:149855835..149855842,-	p@chr7:149855835..149855842 -
Mm9::chr7:150871768..150871785,-	p1@Tnfrsf23
Mm9::chr7:17260966..17260972,-	p1@Ceacam15
Mm9::chr7:17788797..17788806,+	p4@Psg29
Mm9::chr7:17788842..17788851,+	p2@Psg29
Mm9::chr7:17788884..17788890,+	p3@Psg29
Mm9::chr7:19303466..19303478,+	p3@Psg22
Mm9::chr7:29478022..29478029,+	p11@Fbxo27
Mm9::chr7:29478051..29478062,+	p3@Fbxo27
Mm9::chr7:3169146..3169151,-	p4@AU018091
Mm9::chr8:126173640..126173677,+	p@chr8:126173640..126173677 +
Mm9::chr8:90796337..90796350,+	p7@Adcy7
Mm9::chr8:95485242..95485253,+	p@chr8:95485242..95485253 +
Mm9::chr8:95485264..95485279,+	p@chr8:95485264..95485279 +
Mm9::chrX:131570617..131570629,-	p3@ENSMUST00000153610
Mm9::chrX:131570630..131570638,-	p6@ENSMUST00000153610
Mm9::chrX:34758264..34758276,-	p@chrX:34758264..34758276 -
Mm9::chrX:34758325..34758332,-	p@chrX:34758325..34758332 -
Mm9::chrX:35464090..35464097,-	p1@Rhox12
Mm9::chrX:48558793..48558815,-	p@chrX:48558793..48558815 -
Mm9::chrX:53570692..53570717,+	p1@1600025M17Rik
Mm9::chrX:53570819..53570832,+	p1@uc009tga.1
Mm9::chrX:68916840..68916846,+	p1@Gpr50
Mm9::chrX:97990788..97990815,+	p@chrX:97990788..97990815 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}